| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |